{"entity":{"type":"insider","cik":"0001814934","url":"/insider/0001814934","json_url":"/insider/0001814934.json","name":"Avara Management Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":12,"first":"2020-06-22","last":"2024-01-03","span_basis":"filed_date"},"name_variants":[{"name":"Avara Management Ltd","source":"filing","n_filings":12,"first_seen":"2020-06-22","last_seen":"2024-01-03"}],"transactions":[{"id":3159800,"accession":"0001140361-24-000455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-24-000455","line_url":"/filing/0001140361-24-000455#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65803.0,"shares_display":"65,803","price_per_share":28.0444,"price_display":"28.04","price_state":"stated","total_value":1845405.6532,"total_display":"1,845,405.65","total_whole":"1,845,406","shares_owned_after":2477520.0,"shares_owned_after_display":"2,477,520","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-29","filed_date":"2024-01-03","scope":"insider"},{"id":8434343,"accession":"0001140361-23-060204","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-060204","line_url":"/filing/0001140361-23-060204#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":209863.0,"shares_display":"209,863","price_per_share":28.2038,"price_display":"28.20","price_state":"stated","total_value":5918934.0794,"total_display":"5,918,934.08","total_whole":"5,918,934","shares_owned_after":2543323.0,"shares_owned_after_display":"2,543,323","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-28","filed_date":"2023-12-29","scope":"insider"},{"id":8434332,"accession":"0001140361-23-060204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-060204","line_url":"/filing/0001140361-23-060204#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41729.0,"shares_display":"41,729","price_per_share":28.0082,"price_display":"28.01","price_state":"stated","total_value":1168754.1778,"total_display":"1,168,754.18","total_whole":"1,168,754","shares_owned_after":2753186.0,"shares_owned_after_display":"2,753,186","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider"},{"id":8541669,"accession":"0001140361-23-058427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-058427","line_url":"/filing/0001140361-23-058427#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10229.0,"shares_display":"10,229","price_per_share":28.0085,"price_display":"28.01","price_state":"stated","total_value":286498.9465,"total_display":"286,498.95","total_whole":"286,499","shares_owned_after":2794915.0,"shares_owned_after_display":"2,794,915","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-19","scope":"insider"},{"id":8034068,"accession":"0001140361-23-057897","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-057897","line_url":"/filing/0001140361-23-057897#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":364441.0,"shares_display":"364,441","price_per_share":28.9053,"price_display":"28.91","price_state":"stated","total_value":10534276.4373,"total_display":"10,534,276.44","total_whole":"10,534,276","shares_owned_after":2805144.0,"shares_owned_after_display":"2,805,144","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-15","scope":"insider"},{"id":8034065,"accession":"0001140361-23-057897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-057897","line_url":"/filing/0001140361-23-057897#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":307935.0,"shares_display":"307,935","price_per_share":28.9542,"price_display":"28.95","price_state":"stated","total_value":8916011.577,"total_display":"8,916,011.58","total_whole":"8,916,012","shares_owned_after":3169585.0,"shares_owned_after_display":"3,169,585","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-15","scope":"insider"},{"id":6563238,"accession":"0001140361-22-044737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-044737","line_url":"/filing/0001140361-22-044737#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84302.0,"shares_display":"84,302","price_per_share":43.148,"price_display":"43.15","price_state":"stated","total_value":3637462.696,"total_display":"3,637,462.70","total_whole":"3,637,463","shares_owned_after":7795072.0,"shares_owned_after_display":"7,795,072","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-05","filed_date":"2022-12-07","scope":"insider"},{"id":6604767,"accession":"0001140361-22-044471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-044471","line_url":"/filing/0001140361-22-044471#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197766.0,"shares_display":"197,766","price_per_share":43.9783,"price_display":"43.98","price_state":"stated","total_value":8697412.4778,"total_display":"8,697,412.48","total_whole":"8,697,412","shares_owned_after":7879374.0,"shares_owned_after_display":"7,879,374","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-05","scope":"insider"},{"id":6604765,"accession":"0001140361-22-044471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-044471","line_url":"/filing/0001140361-22-044471#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165000.0,"shares_display":"165,000","price_per_share":44.105,"price_display":"44.10","price_state":"stated","total_value":7277325.0,"total_display":"7,277,325.00","total_whole":"7,277,325","shares_owned_after":22225000.0,"shares_owned_after_display":"22,225,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider"},{"id":6721000,"accession":"0001140361-22-035474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-035474","line_url":"/filing/0001140361-22-035474#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32593.0,"shares_display":"32,593","price_per_share":41.05,"price_display":"41.05","price_state":"stated","total_value":1337942.65,"total_display":"1,337,942.65","total_whole":"1,337,943","shares_owned_after":8077140.0,"shares_owned_after_display":"8,077,140","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-30","scope":"insider"},{"id":6479215,"accession":"0001140361-22-034705","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-034705","line_url":"/filing/0001140361-22-034705#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":211380.0,"shares_display":"211,380","price_per_share":41.1681,"price_display":"41.17","price_state":"stated","total_value":8702112.978,"total_display":"8,702,112.98","total_whole":"8,702,113","shares_owned_after":8109733.0,"shares_owned_after_display":"8,109,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-22","filed_date":"2022-09-26","scope":"insider"},{"id":6748426,"accession":"0001140361-22-034416","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-22-034416","line_url":"/filing/0001140361-22-034416#line-3","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125697.0,"shares_display":"125,697","price_per_share":41.253,"price_display":"41.25","price_state":"stated","total_value":5185378.341,"total_display":"5,185,378.34","total_whole":"5,185,378","shares_owned_after":8321113.0,"shares_owned_after_display":"8,321,113","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-22","scope":"insider"},{"id":6748423,"accession":"0001140361-22-034416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-034416","line_url":"/filing/0001140361-22-034416","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":398145.0,"shares_display":"398,145","price_per_share":41.01815969056499,"price_display":"41.02","price_state":"stated","total_value":16331175.19,"total_display":"16,331,175.19","total_whole":"16,331,175","shares_owned_after":22390000.0,"shares_owned_after_display":"22,390,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-20","filed_date":"2022-09-22","scope":"insider","n_lines":2},{"id":6128520,"accession":"0001140361-22-032906","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-032906","line_url":"/filing/0001140361-22-032906#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":237619.0,"shares_display":"237,619","price_per_share":42.739,"price_display":"42.74","price_state":"stated","total_value":10155598.441,"total_display":"10,155,598.44","total_whole":"10,155,598","shares_owned_after":8577140.0,"shares_owned_after_display":"8,577,140","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-09","scope":"insider"},{"id":6128519,"accession":"0001140361-22-032906","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-032906","line_url":"/filing/0001140361-22-032906#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":261881.0,"shares_display":"261,881","price_per_share":42.6596,"price_display":"42.66","price_state":"stated","total_value":11171738.7076,"total_display":"11,171,738.71","total_whole":"11,171,739","shares_owned_after":8814759.0,"shares_owned_after_display":"8,814,759","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-07","filed_date":"2022-09-09","scope":"insider"},{"id":6774537,"accession":"0001140361-22-031349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-031349","line_url":"/filing/0001140361-22-031349#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":44.0,"price_display":"44.00","price_state":"stated","total_value":22000.0,"total_display":"22,000.00","total_whole":"22,000","shares_owned_after":9076640.0,"shares_owned_after_display":"9,076,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-25","filed_date":"2022-08-29","scope":"insider"},{"id":2526104,"accession":"0001140361-20-014508","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-20-014508","line_url":"/filing/0001140361-20-014508#line-5","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; Nogra Group SICAF SIF GG Strategic; Nogra Group SICAF SIF MGG Strategic; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":1400000.0,"total_display":"1,400,000.00","total_whole":"1,400,000","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-18","filed_date":"2020-06-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001802768","name":"Royalty Pharma plc","url":"/issuer/0001802768","role":"Ten percent owner","n_filings":12,"first_seen":"2020-06-22","last_seen":"2024-01-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001814934","retrieved_at":"2026-08-25T15:07:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}